Category: AI

Microsoft’s Bing AI, powered by ChatGPT, is constantly evolving and getting smarter. In fact, the latest update to Bing AI includes more localized knowledge, making it an even more valuable tool for users.

According to Microsoft’s corporate vice president, Rangan Majumder, “The use of natural language processing (NLP) models such as ChatGPT can enable search engines like Bing to understand the user’s intent and provide more personalized and localized search results.”

One of the ways in which Bing AI is becoming more localized is through the integration of local business information into search results. By using ChatGPT’s NLP capabilities, Bing AI can provide users with more relevant information about local businesses and services.

Levi’s, the popular denim brand, has announced that it will be testing AI-generated models to increase inclusivity and personalization in its advertising campaigns. The company will be partnering with customization platform, The Yes, to create a more personalized shopping experience for customers.

The AI-generated models will be used to showcase Levi’s products in advertising campaigns, and will be based on a diverse range of body types and sizes. The aim of the initiative is to promote inclusivity and diversity in the fashion industry and to ensure that all customers feel represented and included.

Artificial intelligence (AI) has the potential to revolutionize the field of organ transplantation, according to experts from the Mayo Clinic. In a recent article published on the Mayo Clinic News Network, the team outlined five ways in which AI could transform the organ transplant process.

The first way is by improving organ matching. “Currently, organ matching is done based on a limited number of factors such as blood type, tissue type, and size,” said Dr. Mikel Prieto, chair of the Division of Transplantation Surgery at the Mayo Clinic in Rochester, Minnesota. “AI can help us incorporate more factors, such as genetic data and biomarkers, to better match donors and recipients.”

The second way is by predicting organ rejection. “AI can help us analyze large amounts of data to identify patterns and predict which patients are at risk for rejection,” said Dr. Prieto. “This can help us intervene early and prevent rejection from occurring.”

A group of scientists from the University of Washington has developed an artificial intelligence (AI) model that can design new proteins, according to a paper published in the journal Science. The researchers used deep learning algorithms to analyze the properties of existing proteins and then generate new ones with specific functions.

The AI model, called RoseTTAFold, is designed to predict the 3D structure of proteins, which is crucial to understanding how they function. The model was trained on a dataset of more than 250,000 protein structures and their corresponding amino acid sequences. Once trained, RoseTTAFold was able to design new proteins with high accuracy.

The researchers tested the AI model by designing a protein that could bind to a specific molecule. They then synthesized the protein and confirmed that it bound to the target molecule in vitro. “This is a major step forward in protein design,” says Dr. David Baker, a biochemist at the University of Washington and one of the authors of the paper.

Wonder Dynamics, a Los Angeles-based startup, has developed an artificial intelligence (AI) app that can replace a person with a computer-generated image (CGI) model in real time. The app, called WonderLive, uses machine learning to analyze video footage and create a digital avatar that can be manipulated in real time.

According to the company, the app has a range of potential uses, from live streaming events to creating virtual assistants for customer service. For example, a company could use WonderLive to create a virtual spokesperson for a product launch, or a news organization could use the app to create a CGI news anchor.

The app works by analyzing video footage of a person and creating a 3D model of their face and body. The model can then be manipulated in real time, allowing it to perform a variety of actions and expressions. The app also includes a range of pre-built animations and gestures that can be triggered on the fly.

Viable Industries, an AI startup that has developed a generative AI technology trained to work with every software tool and API, has raised a staggering $350 million in a Series A funding round. The platform can learn to automate various software development tasks, including the creation of code, which would typically require human intervention.

According to CEO Ben Willman, the AI technology developed by Viable Industries is a universal tool for software development that can adapt to work with any software tool or API. “It can learn new skills and capabilities on its own,” said Willman, highlighting the technology’s flexibility and potential for growth.

Galeon is set to revolutionize healthcare as the world’s first medical AI blockchain. Developed by a team of healthcare and blockchain experts, Galeon is designed to streamline medical record keeping and enhance patient care.

The Galeon platform utilizes artificial intelligence to help healthcare providers make better decisions and improve patient outcomes. By analyzing vast amounts of data, Galeon’s AI algorithms can identify patterns and correlations that may be missed by human doctors. This can lead to more accurate diagnoses and more effective treatments.

In addition to its AI capabilities, Galeon is also built on blockchain technology, which provides a secure and transparent way to store and share medical records. This can help to prevent medical errors and ensure that patients receive the best possible care.

Generative artificial intelligence (AI) is making waves in the healthcare industry by reducing costs and developing new cancer drugs. Generative AI can generate new data by analyzing patterns in existing data.

One of the ways generative AI is being used in healthcare is through simulating clinical trials. Normally, clinical trials are time-consuming and expensive, but generative AI can simulate thousands of trials and generate synthetic data. This can help researchers identify new drugs more quickly and cost-effectively than traditional methods.

Generative AI can also improve the efficiency of drug development. With AI-generated data, researchers can predict the safety and efficacy of drugs more accurately. Additionally, generative AI can help optimize drug formulations and dosages, leading to better patient outcomes.

Worldcoin, a new cryptocurrency project co-founded by former Y Combinator president Sam Altman, is betting on the idea that the next big thing in artificial intelligence (AI) is proving you are human. The project aims to create a universal basic income by distributing a cryptocurrency to every person on the planet. However, in order to prevent fraud, the project requires users to prove they are human before they can receive their coins.

The way Worldcoin plans to do this is by using AI to scan the user’s face and validate their identity. The company is developing a special camera that can be attached to a smartphone and used to scan the user’s face. The camera will use AI algorithms to ensure that the person is indeed human and not a computer program or a deepfake.

Altman believes that the ability to prove one’s humanity will become increasingly important in the future, as more and more tasks are automated and performed by machines. “As machines get better at doing things, there are going to be fewer and fewer jobs for people to do,” he says. “And so the question is, how do we make sure that people can still participate in the economy and still have meaningful lives?”